These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27247711)

  • 21. Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients.
    Chung SW; Cho H; Shin H; Park J; Kim JY; Hong JH; Hur MH; Park MK; Lee YB; Yu SJ; Lee M; Kim YJ; Paeng JC; Yoon JH; Chung JW; Lee JH; Kim HC
    Front Oncol; 2023; 13():1081479. PubMed ID: 36925930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility and safety of liver transplantation or resection after transarterial radioembolization with Yttrium-90 for unresectable hepatocellular carcinoma.
    Labgaa I; Tabrizian P; Titano J; Kim E; Thung SN; Florman S; Schwartz M; Melloul E
    HPB (Oxford); 2019 Nov; 21(11):1497-1504. PubMed ID: 31005494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative Imaging Biomarkers for
    Schobert I; Chapiro J; Nezami N; Hamm CA; Gebauer B; Lin M; Pollak J; Saperstein L; Schlachter T; Savic LJ
    J Nucl Med; 2019 Aug; 60(8):1066-1072. PubMed ID: 30655331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal and Intestinal Excretion of
    Drescher R; Kühnel C; Seifert P; Gühne F; Freesmeyer M
    AJR Am J Roentgenol; 2020 May; 214(5):1158-1164. PubMed ID: 32130046
    [No Abstract]   [Full Text] [Related]  

  • 25. Transarterial Y90 radioembolization versus chemoembolization for patients with hepatocellular carcinoma: A meta-analysis.
    Zhang Y; Li Y; Ji H; Zhao X; Lu H
    Biosci Trends; 2015 Oct; 9(5):289-98. PubMed ID: 26559021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-Term Toxicity after Transarterial Radioembolization with Yttrium-90 Using Resin Microspheres for Neuroendocrine Tumor Liver Metastases.
    Tomozawa Y; Jahangiri Y; Pathak P; Kolbeck KJ; Schenning RC; Kaufman JA; Farsad K
    J Vasc Interv Radiol; 2018 Jun; 29(6):858-865. PubMed ID: 29724520
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Jreige M; Mitsakis P; Van Der Gucht A; Pomoni A; Silva-Monteiro M; Gnesin S; Boubaker A; Nicod-Lalonde M; Duran R; Prior JO; Denys A; Schaefer N
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1215-1222. PubMed ID: 28233086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ablative-Transarterial Radioembolization resulting in complete histopathological response of hepatocellular carcinoma in the resected liver specimen after salvage hepatectomy.
    Chung TK; Leung TW; Chung CH; Leung HH; Lau WY
    Int J Surg Case Rep; 2022 Jan; 90():106679. PubMed ID: 34972009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
    Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
    J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transarterial Radioembolization (TARE) with
    Patel A; Subbanna I; Bhargavi V; Swamy S; Kallur KG; Patil S
    South Asian J Cancer; 2021 Apr; 10(2):81-86. PubMed ID: 34568220
    [No Abstract]   [Full Text] [Related]  

  • 31. Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: Real-Life Efficacy and Safety Analysis of Korean Patients.
    Yim SY; Chun HS; Lee JS; Lim JH; Kim TH; Kim BK; Kim SU; Park JY; Ahn SH; Kim GM; Won JY; Seo YS; Kim YH; Um SH; Kim DY
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of
    Nak D; Küçük NÖ; Çelebioğlu EC; Bilgiç MS; Hayme S; Kır KM
    Mol Imaging Radionucl Ther; 2022 Oct; 31(3):207-215. PubMed ID: 36268887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful Transcatheter Arterial Radioembolization of Hepatocellular Carcinoma Via Left Internal Mammary Artery: A Case Report.
    Alhussaini A; Qazi SA; AlZahrani YA
    Cureus; 2022 Mar; 14(3):e22954. PubMed ID: 35411262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of Life and Cost Considerations: Y-90 Radioembolization.
    Williams SJ; Rilling WS; White SB
    Semin Intervent Radiol; 2021 Oct; 38(4):482-487. PubMed ID: 34629718
    [No Abstract]   [Full Text] [Related]  

  • 35. Transarterial Radioembolization of Hepatocellular Carcinoma, Liver-Dominant Hepatic Colorectal Cancer Metastases, and Cholangiocarcinoma Using Yttrium90 Microspheres: Eight-Year Single-Center Real-Life Experience.
    Pellegrinelli J; Chevallier O; Manfredi S; Dygai-Cochet I; Tabouret-Viaud C; Nodari G; Ghiringhelli F; Riedinger JM; Popoff R; Vrigneaud JM; Cochet A; Aho S; Latournerie M; Loffroy R
    Diagnostics (Basel); 2021 Jan; 11(1):. PubMed ID: 33466706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeated radioembolization in advanced liver cancer.
    Masthoff M; Schindler P; Harders F; Heindel W; Wilms C; Schmidt HH; Pascher A; Stegger L; Rahbar K; Wildgruber M; Köhler M
    Ann Transl Med; 2020 Sep; 8(17):1055. PubMed ID: 33145274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Locoregional Therapies of Cholangiocarcinoma.
    Sommer CM; Kauczor HU; Pereira PL
    Visc Med; 2016 Dec; 32(6):414-420. PubMed ID: 28229076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
    Saini A; Wallace A; Alzubaidi S; Knuttinen MG; Naidu S; Sheth R; Albadawi H; Oklu R
    J Clin Med; 2019 Jan; 8(1):. PubMed ID: 30621040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transarterial strategies for the treatment of unresectable hepatocellular carcinoma: A systematic review.
    Yang B; Liang J; Qu Z; Yang F; Liao Z; Gou H
    PLoS One; 2020; 15(2):e0227475. PubMed ID: 32074102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transarterial radioembolization versus systemic treatment for hepatocellular carcinoma with macrovascular invasion: Analysis of the US National Cancer Database.
    Ahn JC; Lauzon M; Luu M; Friedman ML; Kosari K; Nissen N; Lu SC; Roberts LR; Singal AG; Yang JD
    J Nucl Med; 2021 Apr; 62(12):1692-701. PubMed ID: 33837067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.